Risk Factors Update Summary
- Net losses decreased significantly from $173 million to $82 million in 2023, a positive trend.
- Accumulated deficit decreased from approximately $713 million to $795 million, showing improved financial health.
- Phase 3 ACTION Study initiated for ONC201, with potential impact on regulatory approval process.
Full Text Changes in Most Recent 10-K
Intended use: review the highlighted statements. These are additions to the risk factors disclosure in the most recent 10-K filing compared to the previous 10-K filing. Deleted and moved text is less important and is shown for context.
To view the full company filings, click on the following link to be taken to the SEC EDGAR database landing page for the company: https://www.sec.gov/edgar/browse/?CIK=1117480&owner=exclude
This content requires a 'Free' membership to view. Please create one here.
This content requires a 'Free' membership to view. Please create one here.